• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.29% Nasdaq Down 0.03%

    Ariad Pharmaceuticals Inc. (ARIA)

    -NasdaqGS
    9.07 Up 0.23(2.60%) 4:00PM EDT
    |After Hours : 9.03 Down 0.04 (0.43%) 4:25PM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:8.84
    Open:8.85
    Bid:9.03 x 500
    Ask:9.06 x 3500
    1y Target Est:9.29
    Beta:1.17
    Earnings Date:Aug 4 - Aug 10 (Est.)
    Day's Range:8.82 - 9.07
    52wk Range:4.90 - 9.89
    Volume:2,855,434
    Avg Vol (3m):5,497,030
    Market Cap:1.71B
    P/E (ttm):N/A
    EPS (ttm):-0.88
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ARIAUp 2.60%1.71B
    NVSDown 0.90%251.35B
    PFEDown 0.23%211.08B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):14.09
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.08
    Quarterly EPS Est (Jun-15) :-0.27
    Mean Recommendation*:2.3
    PEG Ratio (5 yr expected):-0.20

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    ARIAD Pharmaceuticals, Inc., an oncology company, engages in the discovery, development, and commercialization of medicines for cancer patients. The company offers Iclusig (ponatinib), a tyrosine kinase inhibitor (TKI) for the treatment of adult p... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback